Annual CFO:
-$95.21M+$61.11M(+39.09%)Summary
- As of today (October 3, 2025), ADPT annual cash from operations is -$95.21 million, with the most recent change of +$61.11 million (+39.09%) on December 31, 2024.
- During the last 3 years, ADPT annual cash from operations has risen by +$97.52 million (+50.60%).
- ADPT annual cash from operations is now -146.35% below its all-time high of $205.40 million, reached on December 31, 2019.
Performance
ADPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$12.43M+$16.05M(+56.36%)Summary
- As of today (October 3, 2025), ADPT quarterly cash from operations is -$12.43 million, with the most recent change of +$16.05 million (+56.36%) on June 30, 2025.
- Over the past year, ADPT quarterly cash from operations has increased by +$4.87 million (+28.16%).
- ADPT quarterly cash from operations is now -104.47% below its all-time high of $278.30 million, reached on March 31, 2019.
Performance
ADPT Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$80.47M+$4.87M(+5.71%)Summary
- As of today (October 3, 2025), ADPT TTM cash from operations is -$80.47 million, with the most recent change of +$4.87 million (+5.71%) on June 30, 2025.
- Over the past year, ADPT TTM cash from operations has increased by +$48.80 million (+37.75%).
- ADPT TTM cash from operations is now -129.49% below its all-time high of $272.89 million, reached on March 31, 2019.
Performance
ADPT TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADPT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +39.1% | +28.2% | +37.8% |
| 3Y3 Years | +50.6% | +73.6% | +61.5% |
| 5Y5 Years | -146.3% | +60.0% | +41.1% |
ADPT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +50.6% | at high | +79.0% | at high | +61.3% |
| 5Y | 5-Year | -146.3% | +50.6% | at high | +80.7% | at high | +61.5% |
| All-Time | All-Time | -146.3% | +50.6% | -104.5% | +80.7% | -129.5% | +61.5% |
ADPT Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$12.43M(-56.4%) | -$80.47M(-5.7%) |
| Mar 2025 | - | -$28.48M(+128.0%) | -$85.34M(-10.4%) |
| Dec 2024 | -$95.21M(-39.1%) | -$12.49M(-53.8%) | -$95.21M(-13.2%) |
| Sep 2024 | - | -$27.07M(+56.4%) | -$109.65M(-15.2%) |
| Jun 2024 | - | -$17.30M(-54.9%) | -$129.27M(-4.6%) |
| Mar 2024 | - | -$38.35M(+42.4%) | -$135.53M(-13.3%) |
| Dec 2023 | -$156.32M(-15.0%) | -$26.93M(-42.3%) | -$156.32M(-1.9%) |
| Sep 2023 | - | -$46.68M(+98.2%) | -$159.41M(+2.8%) |
| Jun 2023 | - | -$23.56M(-60.2%) | -$155.13M(-13.2%) |
| Mar 2023 | - | -$59.15M(+97.0%) | -$178.64M(-2.9%) |
| Dec 2022 | -$183.94M(-4.6%) | -$30.02M(-29.2%) | -$183.94M(-11.5%) |
| Sep 2022 | - | -$42.41M(-9.9%) | -$207.75M(-0.5%) |
| Jun 2022 | - | -$47.06M(-27.0%) | -$208.79M(+5.0%) |
| Mar 2022 | - | -$64.45M(+19.7%) | -$198.94M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$192.73M(+28.8%) | -$53.83M(+23.9%) | -$192.73M(+7.8%) |
| Sep 2021 | - | -$43.44M(+16.7%) | -$178.75M(-2.0%) |
| Jun 2021 | - | -$37.21M(-36.1%) | -$182.46M(+3.5%) |
| Mar 2021 | - | -$58.24M(+46.2%) | -$176.32M(+17.8%) |
| Dec 2020 | -$149.68M(-172.9%) | -$39.84M(-15.5%) | -$149.68M(+9.6%) |
| Sep 2020 | - | -$47.16M(+51.7%) | -$136.63M(+14.2%) |
| Jun 2020 | - | -$31.08M(-1.7%) | -$119.61M(+14.5%) |
| Mar 2020 | - | -$31.61M(+18.0%) | -$104.50M(-150.9%) |
| Dec 2019 | $205.40M(-736.7%) | -$26.79M(-11.1%) | $205.40M(-9.4%) |
| Sep 2019 | - | -$30.14M(+88.7%) | $226.78M(-11.7%) |
| Jun 2019 | - | -$15.97M(-105.7%) | $256.92M(-5.9%) |
| Mar 2019 | - | $278.30M(-5244.2%) | $272.89M(-2471.5%) |
| Dec 2018 | -$32.26M(-7.5%) | -$5.41M(-11.3%) | -$11.51M(+88.7%) |
| Mar 2018 | - | -$6.10M | -$6.10M |
| Dec 2017 | -$34.86M | - | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual cash from operations?
- What is the all-time high annual cash from operations for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual cash from operations year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly cash from operations year-on-year change?
- What is Adaptive Biotechnologies Corporation TTM cash from operations?
- What is the all-time high TTM cash from operations for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation TTM cash from operations year-on-year change?
What is Adaptive Biotechnologies Corporation annual cash from operations?
The current annual cash from operations of ADPT is -$95.21M
What is the all-time high annual cash from operations for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual cash from operations is $205.40M
What is Adaptive Biotechnologies Corporation annual cash from operations year-on-year change?
Over the past year, ADPT annual cash from operations has changed by +$61.11M (+39.09%)
What is Adaptive Biotechnologies Corporation quarterly cash from operations?
The current quarterly cash from operations of ADPT is -$12.43M
What is the all-time high quarterly cash from operations for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly cash from operations is $278.30M
What is Adaptive Biotechnologies Corporation quarterly cash from operations year-on-year change?
Over the past year, ADPT quarterly cash from operations has changed by +$4.87M (+28.16%)
What is Adaptive Biotechnologies Corporation TTM cash from operations?
The current TTM cash from operations of ADPT is -$80.47M
What is the all-time high TTM cash from operations for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high TTM cash from operations is $272.89M
What is Adaptive Biotechnologies Corporation TTM cash from operations year-on-year change?
Over the past year, ADPT TTM cash from operations has changed by +$48.80M (+37.75%)